1. Analysis of indoleamine 2-3 dioxygenase (IDO1) expression in breast cancer tissue by immunohistochemistry

   • Hatem Soliman
   • Bhupendra Rawal
   • Stefan Ambs

   Original article 24 January 2013 Pages: 829 - 837

   

2. Modulation of p38 MAPK signaling enhances dendritic cell activation of human CD4⁺ Th17 responses to ovarian tumor antigen

   • Martin J. Cannon
   • Hannah E. Goyne
   • Maurizio Chiriva-Internati

   Original article 25 January 2013 Pages: 839 - 849

   

3. CD39 is highly involved in mediating the suppression activity of tumor-infiltrating CD8+ T regulatory lymphocytes

   • Alessia Parodi
   • Florinda Battaglia
   • Gilberto Filaci

   Original article 29 January 2013 Pages: 851 - 862

   

4. Increased prevalence of tumour infiltrating immune cells in oropharyngeal tumours in comparison to other subsites: relationship to peripheral immunity

   • Victoria L. Green
   • Anna Michno
   • John Greenman

   Original article 29 January 2013 Pages: 863 - 873

   

5. Specific humoral immune response to the Thomsen-Friedenreich tumor antigen (CD176) in mice after vaccination with the commensal bacterium Bacteroides ovatus D-6

   • Philippe Ulsemer
   • Gemma Henderson
   • Steffen Goletz

   Original article 05 February 2013 Pages: 875 - 887

   

6. A novel melittin-MhIL-2 fusion protein inhibits the growth of human ovarian cancer SKOV₃ cells in vitro and in vivo tumor growth

   • Mingjun Liu
   • Jinbao Zong
   • Guirong Sun

   Original article 27 February 2013 Pages: 889 - 895

   

7. Effects of cyclophosphamide and IL-2 on regulatory CD4⁺ T cell frequency and function in melanoma patients vaccinated with HLA-class I peptides: impact on the antigen-specific T cell response

   • Chiara Camisaschi
   • Paola Filipazzi
   • Chiara Castelli

   Original Article Open access 16 April 2013 Pages: 897 - 908

   

8. Therapeutic regulation of myeloid-derived suppressor cells and immune response to cancer vaccine in patients with extensive stage small cell lung cancer

   • Cristina Iclozan
   • Scott Antonia
   • Dmitry Gabrilovich

   Original Article 16 April 2013 Pages: 909 - 918

   

9. Personalized peptide vaccination: a new approach for advanced cancer as therapeutic cancer vaccine

   • Masanori Noguchi
   • Tetsuro Sasada
   • Kyogo Itoh

   Focussed Research Review 30 November 2012 Pages: 919 - 929

   

10. Circulating tumor cells as therapy-related biomarkers in cancer patients

    • Tobias M. Gorges
    • Klaus Pantel

    Focussed Research Review 12 January 2013 Pages: 931 - 939

    

11. FcγRΙΙB controls the potency of agonistic anti-TNFR mAbs

    • Ann L. White
    • H. T. Claude Chan
    • Martin J. Glennie

    Focussed Research Review 31 March 2013 Pages: 941 - 948

    

12. CD40 immunotherapy for pancreatic cancer

    • Robert H. Vonderheide
    • David L. Bajor
    • Gregory L. Beatty

    Focussed Research Review 16 April 2013 Pages: 949 - 954

    

13. An introduction to mass cytometry: fundamentals and applications

    • Scott D. Tanner
    • Vladimir I. Baranov
    • Thaddeus C. George

    Focussed Research Review 07 April 2013 Pages: 955 - 965

    

14. Harnessing the antigenic fingerprint of each individual cancer for immunotherapy of human cancer: genomics shows a new way and its challenges

    • Pramod K. Srivastava
    • Fei Duan

    Focussed Research Review Open access 19 April 2013 Pages: 967 - 974

    

15. Toward next-generation cancer immunotherapy: 10th Annual Meeting of the Association for Cancer Immunotherapy (CIMT), Mainz, Germany, May 23–25, 2012

    • Björn-Philipp Kloke
    • Sarah Kutscher
    • Sine Reker Hadrup

    Meeting Report 09 January 2013 Pages: 975 - 981